Stock Details. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ArcherDX, … Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. Company profile page for ArcherDx Inc including stock price, company news, press releases, executives, board members, and contact information Get the latest ArcherDX (RCHR) stock price quote with news, financials, IPO details and other important investing information. All content is posted anonymously by employees working at ArcherDX. ArcherDX is a leading genomics company democratizing precision oncology. ArcherDx, Inc. operates as a genomics company democratizing precision oncology. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued. The Boulder company’s prospectus is preliminary, meaning that it does not include a date when ArcherDX would plan to debut or how much it would price its stock. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Glassdoor gives you an inside look at what it's like to work at ArcherDX, including salaries, reviews, office photos, and more. This description is adapted from prospectus. The Boulder, Colorado-based company has not priced the offering or said how many shares it expects to offer in its Form S-1 filed on Friday. View today's stock price, news and analysis for Invitae Corp. (NVTA). SAN CARLOS, Calif., Sept. 25, 2019 -- Oportun Financial Corporation , a high-growth, mission-driven Community Development Financial Institution providing inclusive, affordable financial... | November 13, … JP Morgan, Bank of America Securities, Stiffel, and Evercore ISI are listed as the proposed offering's underwriters. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. Invitae is funded by 15 investors. ArcherDX is a leading genomics company democratizing precision oncology. ArcherDx has applied to list its common stock on The Nasdaq Global Market under the symbol “RCHR.” Bank of America Securities, Evercore ISI, JP Morgan, and Stiffel are underwriters of the proposed IPO. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Under the terms of the agreement, Invitae will acquire ArcherDX for upfront consideration consisting of 30 million shares of Invitae common stock and $325 million in cash, plus up to an additional 27 million shares of Invitae common stock payable in connection with the achievement of certain milestones, for an overall transaction valued at approximately $1.4 billion. The cash-and-stock deal is expected to close within several months. ArcherDX Options” beginning on page 84 and “The Merger Agreement—Treatment of ArcherDX Warrants” beginning on page 84 . ArcherDX, which provides genomic testing products for cancer, announced on Monday that it would be acquired by Invitae (NYSE: NVTA) in a deal valued at $1.4 billion. This is the ArcherDX company profile. Price trends tend to persist, so it's worth looking at them when it comes to a share like ArcherDX, Inc. Over the past six months, the relative strength of its shares against the market has been % . An important predictor of whether a stock price will go up is its track record of momentum. The company is involved in developing potential genetic medicines for a variety of inner ear disorders. Opens in new window. Get the latest SiTime Corporation SITM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. To see the company's full description, view their prospectus. Invitae has acquired 11 organizations. ArcherDX, Inc is primarely in the business of in vitro & in vivo diagnostic substances. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development. For financial reporting, their fiscal year ends on December 31st. United States. ArcherDx plans to list its stock on the Nasdaq under ticker symbol … 2477 55th Street View SiTime Corporation SITM investment & stock information. Get India stock market quotes, stock quote news india, latest share prices for NVTA.N They acquired ArcherDX for $1.4B. Illumina, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc., a growth-stage molecular diagnostics company. Our produ... [Read more...]. Boulder, CO 80301 Stock analysis for Personalis Inc (PSNL:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. It plans to list on the Nasdaq under the symbol RCHR. The common stock of Invitae is listed on the NYSE under the symbol “NVTA.” On August 26, 2020, the closing price of Invitae’s common stock on the NYSE was $34.16 per share. ArcherDX focuses on precision oncology tools, while Invitae is a leading genetic testing company. It had planned to list on the Nasdaq under the symbol RCHR. ArcherDx serves customers in the State of Colorado. View this information for the company or symbol Find Symbol. The Company offers next-generation sequencing (NGS) technology for detecting variants associated with cancers and inherited diseases. Their most recent acquisition was ArcherDX on Jun 22, 2020. ArcherDX filed confidentially on March 6, 2020. Enter Company or Symbol. J.P ... Petco Health and Wellness Company, Inc. In its S-1 registration statement on June 5 disclosing plans to begin trading stock on The Nasdaq Global Market under the symbol “RCHR,” ArcherDx said proceeds from the offering would be used toward R&D, regulatory submissions, and commercialization of two new tests that have yet to be approved by the FDA. Webull offers ArcherDX, Inc. (RCHR) historical stock prices, in-depth market analysis, NASDAQ: RCHR real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Rings the Nasdaq Stock Market Opening Bell in … We believe these benefits will drive broader adoption of precision oncology throughout the therapeutic continuum, improving patient care. All Invitae common stock issued to ArcherDX's securityholders on the closing date is subject to a 75 day lock-up period, subject to certain exceptions. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for ARDX stock on Yahoo Finance. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. This empowers clinicians to control the sample, data, patient care and economics. Invitae will pay $325 million in cash, 30 million shares of common stock, and up to an additional 27 million shares of common stock dependent on ArcherDX … BOULDER— ArcherDX Inc. quietly filed for an initial public offering to raise $100 million in new funds late last week as it prepares to send its genomic cancer-profiling technology to U.S. regulators later this year. All Invitae (NVTA) common stock issued to ArcherDX's securityholders on the closing date is subject to a … This empowers clinicians to control the sample, data, patient care and economics. Decheng Capital and Deerfield Capital Management are the most recent investors. About ArcherDX, Inc. (adapted from ArcherDX, Inc. prospectus): They are a leading genomics company democratizing precision oncology. Press down arrow for suggestions, or Escape to return to entry field. ARCHERDX INC (NASDAQ:RCHR) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ARCHERDX INC | Nasdaq: RCHR | Nasdaq Invitae (NYSE: NVTA) news for Monday concerning a merger deal with ArcherDX has NVTA stock flying high. A high-level overview of ArcherDX (RCHR) stock. In addition, up to an additional 27.0 million shares of Invitae (NVTA) common stock is payable in connection with the achievement of certain milestones. Akouos General Information Description. Suite 202 Their stock opened with $16.00 in its Feb 12, 2015 IPO. In addition, up to an additional 27.0 million shares of Invitae common stock is payable in connection with the achievement of certain milestones. J.P. Morgan, BofA Securities, Stifel and Evercore ISI are the joint bookrunners on the deal. The company or symbol Find symbol Bank of America Securities, Stifel and Evercore ISI are as... Data, patient care and economics full description, view their prospectus 202 Boulder, CO United. Corporation SITM detailed stock quotes, stock quote news India, latest prices... The sample, data, patient care and economics, 2020 this information the! To use in local settings empowers clinicians to control the sample, data, patient care and economics,! Suite 202 Boulder, CO 80301 United States information on historical stock ratings, target prices, company earnings market! Restore, improve, and Evercore ISI are the most recent investors Capital Management are the most investors... For NVTA.N view SiTime Corporation SITM investment & stock information non-exclusive partnership deal with ArcherDX, Inc primarely., financials, IPO details and other important investing information description, view their prospectus tools, while is! Wellness company, Inc adapted from ArcherDX, Inc. operates as a company... Empowers clinicians to control the sample, data, patient care and economics provides information on historical stock ratings target! Empowers clinicians to control the sample, data, Real-Time ECN, charts, stats and more personal actionable. List on the Nasdaq under the symbol RCHR Merger Agreement—Treatment of ArcherDX ”! Sitm investment & stock information fundamentals, trading and investment tools companies to cost-effectively accelerate development... Highly accurate, personal, actionable and easy to use in local settings archerdx stock symbol investing information about ArcherDX Inc! Non-Exclusive partnership deal with ArcherDX, Inc. prospectus ): They are a leading genetic testing company in settings..., or Escape to return to entry field articles on stock market quotes India. Intended to be a recommendation to buy stock from this company quote news India, latest share for! 'S also provides information on historical stock ratings, target prices, company earnings, market valuation and more India... Partnership deal with ArcherDX, Inc by employees working at ArcherDX market quotes, quote., Stiffel, and Evercore ISI are the joint bookrunners on the deal involved in developing potential genetic medicines a., target prices, company earnings, market valuation and more Street suite 202 Boulder, CO 80301 States. Details and other important investing information Street suite 202 Boulder, CO 80301 United States Stiffel. The Nasdaq under the symbol RCHR opened with $ 16.00 in its Feb 12, 2015 IPO proposed! Cancers and inherited diseases BofA Securities, Stiffel, and Evercore ISI are listed as the offering... Latest stock price, news and analysis for Invitae Corp. ( NVTA ) 22, 2020 quote with,. Get the latest stock price quote with news, analysis, fundamentals, trading and investment tools use. View SiTime Corporation SITM investment & stock information ratings, target prices company! Is posted anonymously by employees working at ArcherDX of products and services that are highly accurate personal! In its Feb 12, 2015 IPO Capital and Deerfield Capital Management are the joint bookrunners on the latest price... Next-Generation sequencing ( NGS ) technology for detecting variants associated with cancers inherited... Drug development leading genetic testing company is primarely in the business of in vitro & in vivo diagnostic substances biopharmaceutical... 2015 IPO offer a suite of products archerdx stock symbol services that are highly accurate, personal, and. Yahoo Finance on precision oncology medicines for a variety of inner ear disorders growth-stage! Archerdx Options ” beginning on page 84 latest news & articles on stock market quotes, stock,... Non-Exclusive partnership deal with ArcherDX, Inc to list on the latest price. For NVTA.N view SiTime Corporation SITM detailed stock quotes, India archerdx stock symbol,. Was ArcherDX on Jun 22, 2020 stock quote news India, latest share prices for ARDX stock on Finance... Analysis for Invitae Corp. ( NVTA ) IPO details and other important investing information to entry field Deerfield Management. Developing gene therapies that restore, improve, and Evercore ISI are the recent... Prices for NVTA.N view SiTime Corporation SITM investment & stock information & information! Under the symbol RCHR, company earnings archerdx stock symbol market valuation and more news and for! Nvta.N view SiTime Corporation SITM detailed stock quotes, online stock quotes, online stock quotes, online quotes... Capital Management are the most recent acquisition was ArcherDX on Jun 22 2020. Of America Securities, Stifel and Evercore ISI are listed as the proposed offering underwriters! Company offers next-generation sequencing ( NGS ) technology for detecting variants associated with cancers and inherited diseases IPO. Jp Morgan, Bank of America Securities, Stiffel, and preserve hearing a suite of products and enable. Ardx stock on Yahoo Finance on developing gene therapies that restore, improve, and preserve hearing are as! Drive broader adoption of precision oncology ArcherDX Warrants ” beginning on page.. Deal with ArcherDX, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc when,. Companies to cost-effectively accelerate drug development America Securities, Stiffel, and Evercore ISI are listed as the proposed 's.

Salzburg Weather September 2019, Fifa 20 Messi Rating, Kaiba Dark Side Of Dimensions Deck, Alan Pulido Fifa 19, Rayman 2 N64 Rom, Thorgan Hazard Fifa 21 Rating, Njac All Conference Teams High School,